2020 will be remembered as the year of the pandemic, but it also witnessed a rising trend of consolidation with three high-value acquisitions. This research discusses the advancements that mark the dawn of precision diagnostics, new care delivery models, growth prospects and more.
How are telehealth and telemedicine related to the market-based definition of virtual care? Which are the key companies to watch, and what are their core services? What is the five year revenue outlook for this landscape with its major segments? What are the growth opportunities? Find out more.
Hospitals are under constant pressure to reduce costs. Finding new methods to reduce human errors and improve efficiency, and quality of surgical care is critical. Get a detailed analysis of the current state and future opportunities in the digital operating room landscape.
I love the Alvin Toffler quote, “The great growling engine of change—technology,†for a host of reasons. “Growling†could be overlooked for “change†simply because we are caught in an era and pace of change that leaves our heads spinning, and strategy executives love to talk about change. However, the deliberate use of growling denotes a sense of hostility. My interpretation of this word choice is the foresight to know that technology is an incredibly fickle and risky proposition, and fickleness has a high propensity to create hostile responses based upon our given perspective.
This is exemplified by our 2021 Edition of the Top 50 Emerging Technologies, which showcases technologies at a technology readiness level (TRL) of 5 to 9. Our team spent tens of thousands of hours determining the standouts for the next several years and assessed their viability across our criteria. Our top technologies cannot be ignored, especially with a tidal wave of end-user needs spurred by the recent geopolitical chaos (COVID-19, elections). This has created a renewed view of the impact these technologies can have on many applications.
Schedule a consultation with an industry expert at no charge by contacting us at myfrost@frost.com. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
Data Monetization and Innovative Business Models Propel Growth in the Global MedTech Industry
Read more Request Info
AI Accelerates the Growth and Transformation of the Global Medical Imaging Industry
Read more Request Info
Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Sector
Read more Request Info
Growth Opportunity Analysis of the NA Clinical Documentation Improvement (CDI) Sector
Read more Request Info
Vision 2025—What will Spur Disruptive Changes in the Global Healthcare Industry?
Read more Request Info
Indian Telehealth Industry: Changing Paradigms and the Rise of Virtual Visits and Transformational Growth Hubs
Read more Request Info
New Business Models Drive the Growth of the Global Digital Patient Engagement Solutions Sector
Read more Request Info
Competitive Intensity and Growth Prospects of the Global Consumer Wearables Sector
Read more Request InfoAs the biologics contract development
and manufacturing organization (CDMO) market
expands at double-digit rates, Thermo Fisher
Scientific (TMO) is doubling down on its
portfolio after acquiring Henogen SA (viral
vector manufacturer) and Mesa Biotech, Inc.
earlier this year. PPD’s acquisition will
boost TMO’s position in the CDMO market.
Read more
While there is some light at the end
of the tunnel thanks to COVID-19 vaccines, the
job is far from complete. The distribution of
the vaccine has its own challenges. However,
India has prior experience with large-scale
vaccination programs. India’s Universal
Immunization Programme (UIP), which immunizes
approximately 26.7 million newborns and 29
million pregnant women annually against 12
vaccine-preventable diseases, is one of the
largest public health programs globally.
Read more
With one in six deaths due to cancer,
it is the second-leading cause of death
globally. Approximately 70% of deaths from
cancer occur in low- and middle-income
countries, according to the World Health
Organization. About three-quarters of cancer
patients require hospitalization, and one in
six needs re-hospitalization. Hospital
admission can be of two types, planned (e.g.,
scheduled chemotherapy) or unplanned (e.g.,
admission for nausea). Traditionally, hospital
visits have been the only way for cancer
patients to get the treatment they need.
Read more
The global femtech market was valued at $487 million in 2020 and is expected to reach $522 million by the end of 2021. Fertility solutions will drive the industry’s expansion, reaching $217 million by the end of 2021, followed by menstrual care solutions hitting $168 million by the end of this year. Both segments will be powered by increased adoption and implementation of telehealth and mhealth for next-gen femtech solutions.
Frost & Sullivan’s recent analysis, COVID-19 Pandemic Ignites Enthusiasm for Virtual Care, finds that virtual care is the next growth opportunity across the healthcare space. Requirements to ensure social distancing have transformed virtual care from an essential innovation to a must-have model. Although at a nascent stage, the United States’ virtual care market is expected to achieve significant growth by 2025, reflected in an astounding compound annual growth rate (CAGR) of 40.4%.
Frost & Sullivan’s recent analysis, Technological Advancements and Emerging Applications in the Global Magnetic Resonance Imaging (MRI) Market, Forecast to 2024, finds that the MRI market is diversifying with momentum in the privatization trend. Growing public-private partnerships and an increase in near-replacement time in public domains are expected to attract more MRI system procurements.
Read more
